Gus Alva, MD, DFAPA

3 sessions at 2 meetings

Topics

Schizophrenia & Psychosis (2)DepressionLong-Acting InjectablesMuscarinic & Novel AntipsychoticsTreatment-Resistant Depression

Sessions

NEI Fall Congress 2026

November 5–8, 2026 · Colorado Springs, CO · Full program

  • SessionLunch Industry Session†: MDD & Me: An educational experience about an adjunctive treatment option through a hypothetical patient journey

    November 4, 2026, 12:00–13:00

    Industry-sponsored lunch session following a hypothetical patient journey to illustrate an adjunctive treatment option for major depressive disorder.

    DepressionTreatment-Resistant Depression

  • SessionLunch Industry Session†: COBENFYCast LIVE!™: Front Row to the Patient, Care Partner, and Prescriber Voices

    November 6, 2026, 12:30–13:30

    Live industry-sponsored session featuring patient, care partner, and prescriber perspectives on xanomeline-trospium.

    Muscarinic & Novel AntipsychoticsSchizophrenia & Psychosis

APNA 40th Annual Conference

October 28–31, 2026 · Phoenix, AZ · Full program

  • SessionFrom Clinical Evidence to Administration for a Long-Acting Injectable in Schizophrenia

    October 29, 2026, 07:15–08:45

    Industry-sponsored session on relapse burden in schizophrenia and the role of a long-acting injectable, covering its efficacy and safety data and practical administration considerations.

    Long-Acting InjectablesSchizophrenia & Psychosis

Presents with

Areli · Chanel · Fines Shaw · Hara E. Oyedeji · Rebecca Roma

Speaker listings come from official conference programs and may change — confirm on each meeting's site. Spot an error? Names printed differently on different programs are merged conservatively.

Is this you? Add your photo

Send us a headshot and we'll show it on this page and next to your sessions. Every submission is reviewed by a person before it goes live; we never share your email.

Browse the directory

Recurring meetings